CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD

The multicentered pharmacoepidemiological study «Rifagd» (prevalence and pharmacotherapy of arterial hypertension in children) in 13 cities of Russia was conducted with the purpose of analyzing of pediatricians' approach to the treatment of children's arterial hypertension, including drug...

Full description

Saved in:
Bibliographic Details
Main Authors: L.P. Zharkova, L.V. Kozlova, V.I. Makarova, N.L. Izbenko, O.I. Chirkova, E.I. Temnikova, L.P. Parmenova, M.K. Soboleva, Zh.V. Nefedova, A.L. Barsuk, M.L. Ogneva, L.A. Silverstova, D.V. Dadashin, S.I. Petrova, G.G. Ketova, O.N. Ershova, G.N. Okuneva, S.V. D'yachenko, I.A. Toropova
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2006-06-01
Series:Педиатрическая фармакология
Online Access:https://www.pedpharma.ru/jour/article/view/558
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839587247214559232
author L.P. Zharkova
L.V. Kozlova
V.I. Makarova
N.L. Izbenko
O.I. Chirkova
E.I. Temnikova
L.P. Parmenova
M.K. Soboleva
Zh.V. Nefedova
A.L. Barsuk
M.L. Ogneva
L.A. Silverstova
D.V. Dadashin
S.I. Petrova
G.G. Ketova
O.N. Ershova
G.N. Okuneva
S.V. D'yachenko
I.A. Toropova
author_facet L.P. Zharkova
L.V. Kozlova
V.I. Makarova
N.L. Izbenko
O.I. Chirkova
E.I. Temnikova
L.P. Parmenova
M.K. Soboleva
Zh.V. Nefedova
A.L. Barsuk
M.L. Ogneva
L.A. Silverstova
D.V. Dadashin
S.I. Petrova
G.G. Ketova
O.N. Ershova
G.N. Okuneva
S.V. D'yachenko
I.A. Toropova
author_sort L.P. Zharkova
collection DOAJ
description The multicentered pharmacoepidemiological study «Rifagd» (prevalence and pharmacotherapy of arterial hypertension in children) in 13 cities of Russia was conducted with the purpose of analyzing of pediatricians' approach to the treatment of children's arterial hypertension, including drug choice. This allowed to estimate their experience, knowledge, as well as to direct the way to improvements of quality in medical treatment of patients with arterial hypertension. The majority of pediatricians (83,1%) encounter difficulties in hypertension treatment in connection with guidelines absence (37,3%), medical practice absence (30,4%) and «absence of indications for the application of antihypertensive drugs in pediatrics» (31,9%). for arterial hypertension treatment pediatricians use AgE-inhibitors, diuretics and beta blockers.Key words: rifagd, arterial hypertension, pharmacoepidemiology, questioning of pediatricians, ace inhibitors, diuretics, beta blockers.
format Article
id doaj-art-ff3dba8e82694addaf46f21db2b85abd
institution Matheson Library
issn 1727-5776
2500-3089
language Russian
publishDate 2006-06-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-ff3dba8e82694addaf46f21db2b85abd2025-08-03T19:21:18ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892006-06-01331015554CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGDL.P. ZharkovaL.V. KozlovaV.I. MakarovaN.L. IzbenkoO.I. ChirkovaE.I. TemnikovaL.P. ParmenovaM.K. SobolevaZh.V. NefedovaA.L. BarsukM.L. OgnevaL.A. SilverstovaD.V. DadashinS.I. PetrovaG.G. KetovaO.N. ErshovaG.N. OkunevaS.V. D'yachenkoI.A. ToropovaThe multicentered pharmacoepidemiological study «Rifagd» (prevalence and pharmacotherapy of arterial hypertension in children) in 13 cities of Russia was conducted with the purpose of analyzing of pediatricians' approach to the treatment of children's arterial hypertension, including drug choice. This allowed to estimate their experience, knowledge, as well as to direct the way to improvements of quality in medical treatment of patients with arterial hypertension. The majority of pediatricians (83,1%) encounter difficulties in hypertension treatment in connection with guidelines absence (37,3%), medical practice absence (30,4%) and «absence of indications for the application of antihypertensive drugs in pediatrics» (31,9%). for arterial hypertension treatment pediatricians use AgE-inhibitors, diuretics and beta blockers.Key words: rifagd, arterial hypertension, pharmacoepidemiology, questioning of pediatricians, ace inhibitors, diuretics, beta blockers.https://www.pedpharma.ru/jour/article/view/558
spellingShingle L.P. Zharkova
L.V. Kozlova
V.I. Makarova
N.L. Izbenko
O.I. Chirkova
E.I. Temnikova
L.P. Parmenova
M.K. Soboleva
Zh.V. Nefedova
A.L. Barsuk
M.L. Ogneva
L.A. Silverstova
D.V. Dadashin
S.I. Petrova
G.G. Ketova
O.N. Ershova
G.N. Okuneva
S.V. D'yachenko
I.A. Toropova
CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD
Педиатрическая фармакология
title CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD
title_full CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD
title_fullStr CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD
title_full_unstemmed CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD
title_short CHILDREN'S ARTERIAL HYPERTENSION: DRUG CHOICE. THE RESULTS OF THE PHARMACOEPIDEMIOLOGICAL STUDY RIFAGD
title_sort children s arterial hypertension drug choice the results of the pharmacoepidemiological study rifagd
url https://www.pedpharma.ru/jour/article/view/558
work_keys_str_mv AT lpzharkova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT lvkozlova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT vimakarova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT nlizbenko childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT oichirkova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT eitemnikova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT lpparmenova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT mksoboleva childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT zhvnefedova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT albarsuk childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT mlogneva childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT lasilverstova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT dvdadashin childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT sipetrova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT ggketova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT onershova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT gnokuneva childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT svdyachenko childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd
AT iatoropova childrensarterialhypertensiondrugchoicetheresultsofthepharmacoepidemiologicalstudyrifagd